Another approach involves the use of the PDE5 inhibitor tadalafil that, along with reducing MDSC number and function, appears to reduce the number of circulating and tumor-infiltrating Tregs in patients with HNSCC [65,86]. This evidence concerns the gene PDE5A and head and neck squamous cell carcinoma.